TuHURA Biosciences (HURA) Current Assets (2013 - 2026)

TuHURA Biosciences' Current Assets history runs 14 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• On a quarterly basis, Current Assets fell 51.26% year-over-year to $7.0 million in Q1 2026; TTM through Mar 2026 was $7.0 million, a 51.26% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 76.44% from the prior year.
• Current Assets improved to $7.0 million in Q1 2026 per HURA's latest filing, from $4.6 million in the prior quarter.
• Across five years, Current Assets topped out at $19.6 million in Q4 2024 and bottomed at $783000.0 in Q3 2023.
• The 5-year median for Current Assets is $6.8 million (2024), against an average of $7.8 million.
• Across the five-year window, Current Assets plunged 90.4% in 2023 and soared 371.54% in 2024, its largest moves.
• Year by year, Current Assets stood at $9.2 million in 2022, then plunged by 54.69% to $4.2 million in 2023, then surged by 371.54% to $19.6 million in 2024, then plunged by 76.44% to $4.6 million in 2025, then soared by 51.09% to $7.0 million in 2026.
• Per Business Quant, the three latest HURA Current Assets figures stand at $7.0 million (Q1 2026), $4.6 million (Q4 2025), and $3.5 million (Q3 2025).